|
1
|
Kamangar F, Dores GM and Anderson WF:
Patterns of cancer incidence, mortality, and prevalence across five
continents: Defining priorities to reduce cancer disparities in
different geographic regions of the world. J Clin Oncol.
24:2137–2150. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sakuramoto S, Sasako M, Yamaguchi T,
Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi
Y, Imamura H, et al ACTS-GC Group: Adjuvant chemotherapy for
gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med.
357:1810–1820. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Brambilla G and Martelli A: Genotoxic and
carcinogenic risk to humans of drug-nitrite interaction products.
Mutat Res. 635:17–52. 2007. View Article : Google Scholar
|
|
5
|
Van Cutsem E, Moiseyenko VM, Tjulandin S,
Majlis A, Constenla M, Boni C, Rodrigues A, Fodor M, Chao Y, Voznyi
E, et al V325 Study Group: Phase III study of docetaxel and
cisplatin plus fluorouracil compared with cisplatin and
fluoro-uracil as first-line therapy for advanced gastric cancer: A
report of the V325 Study Group. J Clin Oncol. 24:4991–4997. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tsutani Y, Yoshida K, Sanada Y, Wada Y,
Konishi K, Fukushima M and Okada M: Decreased orotate
phosphoribo-syltransferase activity produces 5-fluorouracil
resistance in a human gastric cancer cell line. Oncol Rep.
20:1545–1551. 2008.PubMed/NCBI
|
|
7
|
Zheng LH, Bao YL, Wu Y, Yu CL, Meng X and
Li YX: Cantharidin reverses multidrug resistance of human hepatoma
HepG2/ADM cells via down-regulation of P-glycoprotein expression.
Cancer Lett. 272:102–109. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kang YK, Kang WK, Shin DB, Chen J, Xiong
J, Wang J, Lichinitser M, Guan Z, Khasanov R, Zheng L, et al:
Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as
first-line therapy in patients with advanced gastric cancer: A
randomised phase III noninferiority trial. Ann Oncol. 20:666–673.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rennicke A, Voigt W, Mueller T, Fruehauf
A, Schmoll HJ, Beyer C and Dempke W: Resistance mechanisms
following cisplatin and oxaliplatin treatment of the human
teratocarcinoma cell line 2102EP. Anticancer Res. 25A:1147–1155.
2005.
|
|
10
|
Tian ML, Yan HY and Row KH: Simultaneous
extraction and separation of liquiritin, glycyrrhizic acid, and
glabridin from licorice root with analytical and preparative
chromatography. Biotechnol Bioprocess Eng; BBE. 13:671–676. 2008.
View Article : Google Scholar
|
|
11
|
Lee JY, Lee JH, Park JH, Kim SY, Choi JY,
Lee SH, Kim YS, Kang SS, Jang EC and Han Y: Liquiritigenin, a
licorice flavonoid, helps mice resist disseminated candidiasis due
to Candida albicans by Th1 immune response, whereas liquiritin, its
glycoside form, does not. Int Immunopharmacol. 9:632–638. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang W, Hu X, Zhao Z, Liu P, Hu Y, Zhou J,
Zhou D, Wang Z, Guo D and Guo H: Antidepressant-like effects of
liquiritin and isoliquiritin from Glycyrrhiza uralensis in the
forced swimming test and tail suspension test in mice. Prog
Neuropsychopharmacol Biol Psychiatry. 32:1179–1184. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dong S, Inoue A, Zhu Y, Tanji M and Kiyama
R: Activation of rapid signaling pathways and the subsequent
transcriptional regulation for the proliferation of breast cancer
MCF-7 cells by the treatment with an extract of Glycyrrhiza glabra
root. Food Chem Toxicol. 45:2470–2478. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Aboue A and Al-Shawi AAA: Liquiritin (LG),
isolated and identified from Radix Glycyrrhizae (RG), inhibits the
proliferation and induces apoptosis of human gastric cancer cells
(MGC-803). Int J Curr Microbiol Appl Sci. 3:89–98. 2014.
|
|
15
|
Gao YX, Cheng BF, Lian JJ, Guo D-D, Qin
J-W, Zhang Y-B, Yang H-J, Wang M, Wang L and Feng Z-W: Liquiritin,
a flavone compound from licorice, inhibits IL-1β-induced
inflammatory responses in SW982 human synovial cells. J Funct
Foods. 33:142–148. 2017. View Article : Google Scholar
|
|
16
|
Selvakumaran M, Pisarcik DA, Bao R, Yeung
AT and Hamilton TC: Enhanced cisplatin cytotoxicity by disturbing
the nucleotide excision repair pathway in ovarian cancer cell
lines. Cancer Res. 63:1311–1316. 2003.PubMed/NCBI
|
|
17
|
Kim YW, Ki SH, Lee JR, Lee SJ, Kim CW, Kim
SC and Kim SG: Liquiritigenin, an aglycone of liquiritin in
Glycyrrhizae radix, prevents acute liver injuries in rats induced
by acetaminophen with or without buthionine sulfoximine. Chem Biol
Interact. 161:125–138. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vanella L, Di Giacomo C, Acquaviva R,
Barbagallo I, Cardile V, Kim DH, Abraham NG and Sorrenti V:
Apoptotic markers in a prostate cancer cell line: Effect of ellagic
acid. Oncol Rep. 30:2804–2810. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang XH, Zheng X, Cao JG, Xiang HL, Liu F
and Lv Y: 8-Bromo-7-methoxychrysin-induced apoptosis of
hepatocellular carcinoma cells involves ROS and JNK. World J
Gastroenterol. 16:3385–3393. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gyrd-Hansen M and Meier P: IAPs: From
caspase inhibitors to modulators of NF-kappaB, inflammation and
cancer. Nat Rev Cancer. 10:561–574. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang ZJ, Chee CE, Huang S and Sinicrope F:
Autophagy modulation for cancer therapy. Cancer Biol Ther.
11:169–176. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhai B, Hu F, Jiang X, Xu J, Zhao D, Liu
B, Pan S, Dong X, Tan G, Wei Z, et al: Inhibition of Akt reverses
the acquired resistance to sorafenib by switching protective
autophagy to autophagic cell death in hepatocellular carcinoma. Mol
Cancer Ther. 13:1589–1598. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao D, Jiang Y, Dong X, Liu Z, Qu B,
Zhang Y, Ma N and Han Q: Arsenic trioxide reduces drug resistance
to adriamycin in leukemic K562/A02 cells via multiple mechanisms.
Biomed Pharmacother. 65:354–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao Y, You H, Liu F, An H, Shi Y, Yu Q
and Fan D: Differentially expressed gene profiles between multidrug
resistant gastric adenocarcinoma cells and their parental cells.
Cancer Lett. 185:211–218. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang XW, Bu P, Liu L, Zhang XZ and Li J:
Overexpression of long non-coding RNA PVT1 in gastric cancer cells
promotes the development of multidrug resistance. Biochem Biophys
Res Commun. 462:227–232. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang S, Chen M, Shen Y, Shen W, Guo H,
Gao Q and Zou X: Inhibition of activated Stat3 reverses drug
resistance to chemotherapeutic agents in gastric cancer cells.
Cancer Lett. 315:198–205. 2012. View Article : Google Scholar
|
|
27
|
Ganta S and Amiji M: Coadministration of
Paclitaxel and curcumin in nanoemulsion formulations to overcome
multidrug resistance in tumor cells. Mol Pharm. 6:928–939. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim MK, Choi HS, Cho SG, Shin YC and Ko
SG: Rubus coreanus Miquel extract causes apoptosis of
doxorubicin-resistant NCI/ADR-RES ovarian cancer cells via JNK
phosphorylation. Mol Med Rep. 13:4065–4072. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou Y and Ho WS: Combination of
liquiritin, isoliquiritin and isoliquirigenin induce apoptotic cell
death through upregulating p53 and p21 in the A549 non-small cell
lung cancer cells. Oncol Rep. 31:298–304. 2014. View Article : Google Scholar
|
|
30
|
Matsumoto H, Inaba H, Kishi M, Tominaga S,
Hirayama M and Tsuda T: Orally administered delphinidin
3-rutinoside and cyanidin 3-rutinoside are directly absorbed in
rats and humans and appear in the blood as the intact forms. J
Agric Food Chem. 49:1546–1551. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hagiwara Y, Kasukabe T, Kaneko Y, Niitsu N
and Okabe-Kado J: Ellagic acid, a natural polyphenolic compound,
induces apoptosis and potentiates retinoic acid-induced
differentiation of human leukemia HL-60 cells. Int J Hematol.
92:136–143. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang ZC and Ma J: Actein enhances TRAIL
effects on suppressing gastric cancer progression by activating
p53/Caspase-3 signaling. Biochem Biophys Res Commun. Nov
30–2016.Epub ahead of print. View Article : Google Scholar
|
|
33
|
Kumar A, Wessels D, Daniels KJ, Alexander
H, Alexander S and Soll DR: Sphingosine-1-phosphate plays a role in
the suppression of lateral pseudopod formation during Dictyostelium
discoideum cell migration and chemotaxis. Cell Motil Cytoskeleton.
59:227–241. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li G, Yang F, Gu S, Li Z and Xue M:
MicroRNA-101 induces apoptosis in cisplatin-resistant gastric
cancer cells by targeting VEGF-C. Mol Med Rep. 13:572–578. 2016.
View Article : Google Scholar
|
|
35
|
Schwartz GK and Shah MA: Targeting the
cell cycle: A new approach to cancer therapy. J Clin Oncol.
23:9408–9421. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Aggarwal P, Vaites LP, Kim JK, Mellert H,
Gurung B, Nakagawa H, Herlyn M, Hua X, Rustgi AK, McMahon SB, et
al: Nuclear cyclin D1/CDK4 kinase regulates CUL4 expression and
triggers neoplastic growth via activation of the PRMT5
methyl-transferase. Cancer Cell. 18:329–340. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bockstaele L, Bisteau X, Paternot S and
Roger PP: Differential regulation of cyclin-dependent kinase 4
(CDK4) and CDK6, evidence that CDK4 might not be activated by CDK7,
and design of a CDK6 activating mutation. Mol Cell Biol.
29:4188–4200. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Perisanidis C, Perisanidis B, Wrba F,
Brandstetter A, El Gazzar S, Papadogeorgakis N, Seemann R, Ewers R,
Kyzas PA and Filipits M: Evaluation of immunohistochemical
expression of p53, p21, p27 cyclin D1, and Ki67 in oral and
oropharyngeal squamous cell carcinoma. J Oral Pathol Med. 41:40–46.
2012. View Article : Google Scholar
|
|
39
|
Kim YA, Lee WH, Choi TH, Rhee SH, Park KY
and Choi YH: Involvement of p21WAF1/CIP1, pRB, Bax and NF-kappaB in
induction of growth arrest and apoptosis by resveratrol in human
lung carcinoma A549 cells. Int J Oncol. 23:1143–1149.
2003.PubMed/NCBI
|
|
40
|
Liu P, Wang X, Hu C and Hu T: Inhibition
of proliferation and induction of apoptosis by trimethoxyl stilbene
(TMS) in a lung cancer cell line. Asian Pac J Cancer Prev.
12:2263–2269. 2011.
|
|
41
|
Le NT and Richardson DR: The role of iron
in cell cycle progression and the proliferation of neoplastic
cells. Biochim Biophys Acta. 1603:31–46. 2002.PubMed/NCBI
|
|
42
|
Alao JP: The regulation of cyclin D1
degradation: Roles in cancer development and the potential for
therapeutic invention. Mol Cancer. 6:242007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Horn HF and Vousden KH: Coping with
stress: Multiple ways to activate p53. Oncogene. 26:1306–1316.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chatterjee SJ, Datar R, Youssefzadeh D,
George B, Goebell PJ, Stein JP, Young L, Shi SR, Gee C, Groshen S,
et al: Combined effects of p53, p21, and pRb expression in the
progression of bladder transitional cell carcinoma. J Clin Oncol.
22:1007–1013. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Chen MB, Wu XY, Gu JH, Guo QT, Shen WX and
Lu PH: Activation of AMP-activated protein kinase contributes to
doxorubicin-induced cell death and apoptosis in cultured myocardial
H9c2 cells. Cell Biochem Biophys. 60:311–322. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Circu ML and Aw TY: Glutathione and
modulation of cell apoptosis. Biochim Biophys Acta. 1823:1767–1777.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Andersen JL and Kornbluth S: The tangled
circuitry of metabolism and apoptosis. Mol Cell. 49:399–410. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Suzuki Y, Nakabayashi Y, Nakata K, Reed JC
and Takahashi R: X-linked inhibitor of apoptosis protein (XIAP)
inhibits caspase-3 and -7 in distinct modes. J Biol Chem.
276:27058–27063. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Xiong Y, Lu QJ, Zhao J and Wu GY:
Metformin inhibits growth of hepatocellular carcinoma cells by
inducing apoptosis via mitochondrion-mediated pathway. Asian Pac J
Cancer Prev. 13:3275–3279. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hasan TN, B LG, Shafi G, Al-Hazzani AA and
Alshatwi AA: Anti-proliferative effects of organic extracts from
root bark of Juglans Regia L. (RBJR) on MDA-MB-231 human breast
cancer cells: Role of Bcl-2/Bax, caspases and Tp53. Asian Pac J
Cancer Prev. 12:525–530. 2011.PubMed/NCBI
|
|
51
|
Sträter J, Herter I, Merkel G, Hinz U,
Weitz J and Möller P: Expression and prognostic significance of
APAF-1, caspase-8 and caspase-9 in stage II/III colon carcinoma:
Caspase-8 and caspase-9 is associated with poor prognosis. Int J
Cancer. 127:873–880. 2010.
|
|
52
|
Schleicher SM, Moretti L, Varki V and Lu
B: Progress in the unraveling of the endoplasmic reticulum
stress/autophagy pathway and cancer: Implications for future
therapeutic approaches. Drug Resist Updat. 13:79–86. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Chen ZH, Lam HC, Jin Y, Kim HP, Cao J, Lee
SJ, Ifedigbo E, Parameswaran H, Ryter SW and Choi AM: Autophagy
protein microtubule-associated protein 1 light chain-3B (LC3B)
activates extrinsic apoptosis during cigarette smoke-induced
emphysema. Proc Natl Acad Sci USA. 107:18880–18885. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Klionsky DJ, Abeliovich H, Agostinis P,
Agrawal DK, Aliev G, Askew DS, Baba M, Baehrecke EH, Bahr BA,
Ballabio A, et al: Guidelines for the use and interpretation of
assays for monitoring autophagy in higher eukaryotes. Autophagy.
4:151–175. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Yue Z, Jin S, Yang C, Levine AJ and Heintz
N: Beclin 1, an autophagy gene essential for early embryonic
development, is a haploinsufficient tumor suppressor. Proc Natl
Acad Sci USA. 100:15077–15082. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Mizushima N and Yoshimori T: How to
interpret LC3 immuno-blotting. Autophagy. 3:542–545. 2007.
View Article : Google Scholar : PubMed/NCBI
|
